Last reviewed · How we verify

ovaria comp 10 globuli 3 times per day 24 weeks

Heidelberg University · FDA-approved active Small molecule Quality 2/100

ovaria comp 10 globuli 3 times per day 24 weeks is a Small molecule drug developed by Heidelberg University. It is currently FDA-approved. Also known as: placebo globuli 3 times per day 12 weeks.

At a glance

Generic nameovaria comp 10 globuli 3 times per day 24 weeks
Also known asplacebo globuli 3 times per day 12 weeks
SponsorHeidelberg University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ovaria comp 10 globuli 3 times per day 24 weeks

What is ovaria comp 10 globuli 3 times per day 24 weeks?

ovaria comp 10 globuli 3 times per day 24 weeks is a Small molecule drug developed by Heidelberg University.

Who makes ovaria comp 10 globuli 3 times per day 24 weeks?

ovaria comp 10 globuli 3 times per day 24 weeks is developed and marketed by Heidelberg University (see full Heidelberg University pipeline at /company/heidelberg-university).

Is ovaria comp 10 globuli 3 times per day 24 weeks also known as anything else?

ovaria comp 10 globuli 3 times per day 24 weeks is also known as placebo globuli 3 times per day 12 weeks.

What development phase is ovaria comp 10 globuli 3 times per day 24 weeks in?

ovaria comp 10 globuli 3 times per day 24 weeks is FDA-approved (marketed).

Related